Levitra

...

High court sides with Merrill to limit lawsuits Time settles Spitzer inquiry for $4.5 million Regulators charge 15 with securities fraud L-3 buys two military-products makers Citigroup adds chairman title for its CEO Phillips-Van Heusen shares rise with forecast NYPD to begin growing again this summer MORE NEWS +COMPLETE TABLE OF CONTENTS +VIEW THIS WEEK'S COVER PREMIUM CONTENT Downtown picks up, despite flap While turmoil plagues rebuilding efforts at the World Trade Center, the commercial office market in lower Manhattan is on the upswing...

AG race turns nasty; hopefuls trade barbs Eliot Spitzer may have elevated New York attorney general to one of the most powerful regulatory positions in the country, but his would-be successors seem determined to wallow in petty political misdeeds...

Top chefs fire up giant eateries In the past six months, no fewer than 10 mega-restaurants, headed by esteemed culinary talents like Geoffrey Zakarian and Nobu Matsuhisa, have opened in Manhattan...

MTA-displaced get loans Seedco, a community development nonprofit, is allocating $3 million to help businesses being displaced by construction of the planned transit hub in lower Manhattan...

Pioneer faces perils ITG's technology has entered the mains...

(SGP Powerrating), joint U.S.

promoters of Hypertension is one of the most common medical conditions, along with diabetes and high cholesterol, associated with ED.

In addition, many blood-pressure lowering medications, particularly beta-blockers and diuretics, any adversely affect erectile function.

The study was conducted at 98 primary care sites in Germany and involved 354 patients over the age of 18 who had experienced ED for more than 6 months.

SGP closed Wednesday's regular trading session at $19.30, down 3 cents.

GSK is currently trading at $54.57, up 93 cents, or 1.73%, in pre-market activity.

Copyright(c) 2006 RealTimeTraders.com, Inc.

All Rights Reserved <<< Return More BREAKING NEWS >...